205 related articles for article (PubMed ID: 30098778)
1. MicroRNA-based classifiers for diagnosis of oral cavity squamous cell carcinoma in tissue and plasma.
Pedersen NJ; Jensen DH; Lelkaitis G; Kiss K; Charabi BW; Ullum H; Specht L; Schmidt AY; Nielsen FC; von Buchwald C
Oral Oncol; 2018 Aug; 83():46-52. PubMed ID: 30098778
[TBL] [Abstract][Full Text] [Related]
2. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
3. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
[TBL] [Abstract][Full Text] [Related]
4. Unveiling the Potential of Serum MiR-483-5p: A Promising Diagnostic and Prognostic Biomarker in OLP and OSCC Patients by
Soltaninezhad P; Arab F; Mohtasham N; FakherBaheri M; Kavishahi NN; Aghaee-Bakhtiari SH; Zare-Mahmoodabadi R; Pakfetrat A; Taban KI; Mohajertehran F
Curr Pharm Des; 2024; 30(4):310-322. PubMed ID: 38310566
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
[TBL] [Abstract][Full Text] [Related]
6. Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
Momen-Heravi F; Trachtenberg AJ; Kuo WP; Cheng YS
J Dent Res; 2014 Jul; 93(7 Suppl):86S-93S. PubMed ID: 24718111
[TBL] [Abstract][Full Text] [Related]
7. Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma.
Gai C; Camussi F; Broccoletti R; Gambino A; Cabras M; Molinaro L; Carossa S; Camussi G; Arduino PG
BMC Cancer; 2018 Apr; 18(1):439. PubMed ID: 29669525
[TBL] [Abstract][Full Text] [Related]
8. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
9. miR-200b-3p in plasma is a potential diagnostic biomarker in oral squamous cell carcinoma.
Sun G; Cao Y; Wang P; Song H; Bie T; Li M; Huai D
Biomarkers; 2018 Mar; 23(2):137-141. PubMed ID: 28135849
[TBL] [Abstract][Full Text] [Related]
10. Next-generation Sequencing for microRNA Profiling: MicroRNA-21-3p Promotes Oral Cancer Metastasis.
Tseng HH; Tseng YK; You JJ; Kang BH; Wang TH; Yang CM; Chen HC; Liou HH; Liu PF; Ger LP; Tsai KW
Anticancer Res; 2017 Mar; 37(3):1059-1066. PubMed ID: 28314265
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of miRNA-expression and clinical tumour parameters in oral squamous cell carcinoma (OSCC).
Moratin J; Hartmann S; Brands R; Brisam M; Mutzbauer G; Scholz C; Seher A; Müller-Richter U; Kübler AC; Linz C
J Craniomaxillofac Surg; 2016 Jul; 44(7):876-81. PubMed ID: 27210505
[TBL] [Abstract][Full Text] [Related]
12. Alterations in miRNA expression patterns in whole blood of OSCC patients.
Ries J; Vairaktaris E; Kintopp R; Baran C; Neukam FW; Nkenke E
In Vivo; 2014; 28(5):851-61. PubMed ID: 25189899
[TBL] [Abstract][Full Text] [Related]
13. A panel of microRNAs can be used to determine oral squamous cell carcinoma.
Prasad G; Seers C; Reynolds E; McCullough MJ
J Oral Pathol Med; 2017 Nov; 46(10):940-948. PubMed ID: 28512746
[TBL] [Abstract][Full Text] [Related]
14. miR-186, miR-3651 and miR-494: potential biomarkers for oral squamous cell carcinoma extracted from whole blood.
Ries J; Vairaktaris E; Agaimy A; Kintopp R; Baran C; Neukam FW; Nkenke E
Oncol Rep; 2014 Mar; 31(3):1429-36. PubMed ID: 24452363
[TBL] [Abstract][Full Text] [Related]
15. Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.
Manikandan M; Deva Magendhra Rao AK; Rajkumar KS; Rajaraman R; Munirajan AK
J Oral Pathol Med; 2015 Nov; 44(10):792-800. PubMed ID: 25482863
[TBL] [Abstract][Full Text] [Related]
16. Profiling salivary miRNA expression levels in Fanconi anemia patients - a pilot study.
Tang KD; Amenábar JM; Schussel JL; Torres-Pereira CC; Bonfim C; Dimitrova N; Hartel G; Punyadeera C
Odontology; 2024 Jan; 112(1):299-308. PubMed ID: 37458838
[TBL] [Abstract][Full Text] [Related]
17. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
18. miR-204-5p regulates cell proliferation and metastasis through inhibiting CXCR4 expression in OSCC.
Wang X; Li F; Zhou X
Biomed Pharmacother; 2016 Aug; 82():202-7. PubMed ID: 27470356
[TBL] [Abstract][Full Text] [Related]
19. Circulating MicroRNA-21 Expression as a Novel Serum Biomarker for Oral Sub-Mucous Fibrosis and Oral Squamous Cell Carcinoma.
Singh P; Srivastava AN; Sharma R; Mateen S; Shukla B; Singh A; Chandel S
Asian Pac J Cancer Prev; 2018 Apr; 19(4):1053-1057. PubMed ID: 29699056
[TBL] [Abstract][Full Text] [Related]
20. Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer.
Liu CJ; Kao SY; Tu HF; Tsai MM; Chang KW; Lin SC
Oral Dis; 2010 May; 16(4):360-4. PubMed ID: 20233326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
